IRIS
LENCI, ILARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.404
AS - Asia 2.588
EU - Europa 861
SA - Sud America 348
AF - Africa 29
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 1
Totale 11.237
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.329
SG - Singapore 1.699
CN - Cina 321
BR - Brasile 289
HK - Hong Kong 209
IT - Italia 164
IE - Irlanda 155
DE - Germania 118
VN - Vietnam 114
GB - Regno Unito 93
RU - Federazione Russa 91
KR - Corea 76
IN - India 53
CA - Canada 41
PL - Polonia 32
SE - Svezia 30
FI - Finlandia 27
FR - Francia 26
AR - Argentina 25
MX - Messico 25
UA - Ucraina 25
JP - Giappone 23
AT - Austria 21
ID - Indonesia 19
ES - Italia 16
NL - Olanda 14
BD - Bangladesh 13
BE - Belgio 13
CZ - Repubblica Ceca 11
ZA - Sudafrica 10
IR - Iran 9
LT - Lituania 9
TR - Turchia 8
VE - Venezuela 8
EC - Ecuador 7
IQ - Iraq 7
CH - Svizzera 6
EG - Egitto 6
MA - Marocco 5
PK - Pakistan 5
PY - Paraguay 5
CO - Colombia 4
EU - Europa 4
IL - Israele 4
QA - Qatar 4
TM - Turkmenistan 4
CL - Cile 3
HN - Honduras 3
KE - Kenya 3
MD - Moldavia 3
OM - Oman 3
PE - Perù 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BG - Bulgaria 2
SA - Arabia Saudita 2
SV - El Salvador 2
TW - Taiwan 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AO - Angola 1
AU - Australia 1
BB - Barbados 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
CV - Capo Verde 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GR - Grecia 1
GY - Guiana 1
JO - Giordania 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
MY - Malesia 1
NG - Nigeria 1
NO - Norvegia 1
PA - Panama 1
PH - Filippine 1
RO - Romania 1
TN - Tunisia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 11.237
Salva come PNG Salva come JPEG
Città #
Wilmington 1.914
Houston 1.570
Woodbridge 520
Singapore 519
Fairfield 369
New York 351
Chandler 321
Ashburn 303
Hong Kong 205
Beijing 176
Dublin 134
Seattle 118
Cambridge 115
Los Angeles 109
Medford 105
Ann Arbor 91
Santa Clara 91
The Dalles 90
Rome 60
Lawrence 48
Munich 47
Ho Chi Minh City 44
Buffalo 36
Council Bluffs 36
Nuremberg 31
San Diego 30
São Paulo 27
Menlo Park 26
Dallas 25
Warsaw 25
Chicago 24
London 24
Seoul 23
Dearborn 21
Hanoi 21
Chennai 20
Tokyo 20
Montreal 18
Palo Alto 18
Redondo Beach 17
Mexico City 16
Brooklyn 15
Creede 14
Denver 14
Engelhard 14
Jakarta 14
Moscow 14
Helsinki 13
Orem 13
Stockholm 13
Brussels 12
Vienna 12
Atlanta 11
Jacksonville 11
Phoenix 11
Washington 11
Boardman 10
Poplar 10
Redwood City 10
Rio de Janeiro 10
San Francisco 10
Shanghai 10
Colorado Springs 9
Toronto 9
Hangzhou 8
Hefei 8
Lappeenranta 8
Miami 8
Biên Hòa 7
Brno 7
Chandigarh 7
Johannesburg 7
Manchester 7
Nanjing 7
Frankfurt am Main 6
Hounslow 6
Milan 6
Curitiba 5
Porto Alegre 5
Salt Lake City 5
St. George 5
Tehran 5
Boston 4
Cagliari 4
Campinas 4
Cassino 4
Charlotte 4
Doha 4
Dong Ket 4
Elk Grove Village 4
Goiânia 4
Haiphong 4
Hải Dương 4
Islington 4
Joinville 4
Kilburn 4
La Veta 4
Las Vegas 4
Norwalk 4
Raleigh 4
Totale 8.217
Salva come PNG Salva come JPEG
Nome #
HCV-RNA quantification in liver bioptic samples and extrahepatic compartments, using the abbott RealTime HCV assay 484
Pitfalls in the reporting of upper endoscopy features in cirrhotic patients 431
Evidence of Spontaneous Post-transplant HCV Eradication in Two Failed DAA Treatments Awaiting Liver Transplantation 398
Improvement of ALT decay kinetics by all-oral HCV treatment: Role of NS5A inhibitors and differences with IFN-based regimens 396
Ab initio Everolimus-based Versus Standard Calcineurin Inhibitor Immunosuppression Regimen in Liver Transplant Recipients 342
Sofosbuvir plus daclatasvir with or without ribavirin is safe and effective for post-transplant hepatitis C recurrence and severe fibrosis and cirrhosis: A prospective study 332
Tips for TIPS: A combined percutaneous and transjugular approach for intrahepatic portosystemic shunt placement after liver transplant 325
An unusual duodenal polyp causing anemia in a liver-transplanted patient 324
HDV can constrain HBV genetic evolution in hbsag: Implications for the identification of innovative pharmacological targets 320
Clinical Operational Tolerance and Immunosuppression Minimization in Kidney Transplantation: Where Do We Stand? 317
Hepatitis B virus recurrence after liver transplantation: An old tale or a clear and present danger? 311
Trans-splenic Embolization Plus Partial Splenic Embolization for Management of Variceal Bleeding Due to Left-Sided Portal Hypertension 285
Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows 283
Pro-inflammatory signalling and gut-liver axis in non-alcoholic and alcoholic steatohepatitis: differences and similarities along the path 283
Effect of direct-acting antivirals on future occurrence of hepatocellular carcinoma in compensated cirrhotic patients 272
Impact of new DAA therapy on real clinical practice: A multicenter region-wide cohort study 272
Recurrence of hepatocellular carcinoma after direct acting antiviral treatment for hepatitis C virus infection: Literature review and risk analysis 264
Renal Function, Adherence and Quality of Life Improvement After Conversion From Immediate to Prolonged-Release Tacrolimus in Liver Transplantation: Prospective Ten-Year Follow-Up Study 247
HCV resistance compartmentalization within tumoral and non-tumoral liver in transplanted patients with hepatocellular carcinoma 236
Dual role of bile acids on the biliary epithelium: Friend or foe? 217
Liver Transplantation For HDV/HBV Coinfection In Italy: An Intention-To-Treat Analysis Of Long-Term Outcomes 201
Platelets and hepatocellular cancer: Bridging the bench to the clinics 200
Domino liver transplantation: Where are we now? 194
Evaluation of liver fibrosis in cirrhotic patients: comparison between elastosonography and fibroscan 191
Prevention of hepatitis C recurrence by bridging sofosbuvir/ribavirin from pre- to post-liver transplant: A real-life strategy 190
Liver transplantation for hepatocellular carcinoma: Where do we stand? 188
Vascular anomalies of the celiac trunk and implications in treatment of HCC with TACE. Description of a case and review of the literature 186
De novo malignancies after liver transplantation: The effect of immunosuppression-personal data and review of literature 172
Daclatasvir, sofosbuvir with or without ribavirin for 24 weeks in hepatitis C genotype 3 cirrhosis: A real-life study 143
Transarterial chemoembolization for hepatocellular carcinoma in Fontan surgery patient 123
Cholangiocarcinoma: Bridging the translational gap from preclinical to clinical development and implications for future therapy 119
Genetic Determinants in a Critical Domain of NS5A Correlate with Hepatocellular Carcinoma in Cirrhotic Patients Infected with HCV Genotype 1b 107
Serum Levels of Granulocyte-Macrophage-colony-stimulating Factor and Stem-cell Factor During Liver Regeneration after Partial Hepatectomy in Humans 103
Natremia and liver transplantation: The right amount of salt for a good recipe 92
Functional Role of the Secretin/Secretin Receptor Signaling During Cholestatic Liver Injury 82
Cyclic AMP Signaling in Biliary Proliferation: A Possible Target for Cholangiocarcinoma Treatment? 82
Current strategies to minimize ischemia-reperfusion injury in liver transplantation: a systematic review 82
Gastrointestinal endoscopy in cirrhotic patient: Issues on the table 81
Molecular mechanisms linking risk factors to cholangiocarcinoma development 81
Resistance analysis and treatment outcomes in hepatitis C virus genotype 3-infected patients within the Italian network VIRONET-C 78
COVID-19 in normal, diseased and transplanted liver 77
Liver transplantation performed in a SARS-CoV-2 positive hospitalized recipient using a SARS-CoV-2 infected donor 74
Electronic Outpatient Referral System for Liver Transplant Improves Appropriateness and Allows First Visit Triage 72
The acquisition of positively charged amino acids in HBsAg C-terminus correlates with HBV-induced liver cancer in vivo, impairs HBsAg secretion and affects its structural stability in vitro 71
null 71
Chronic rejection after liver transplantation: Opening the Pandora's box 71
Successful clinical and virological outcomes of liver transplantation for HDV/HBV-related disease after long-term discontinuation of hepatitis B immunoglobulins 70
Overview of prognostic systems for hepatocellular carcinoma and ITA.LI.CA external validation of MESH and CNLC classifications 68
Secondary bile acids and the biliary epithelia: The good and the bad 66
Towards tolerance in liver transplantation 64
Correction to: Immunosuppressive regimens for adult liver transplant recipients in real-life practice: consensus recommendations from an Italian Working Group (Hepatology International, (2020), 14, 6, (930-943), 10.1007/s12072-020-10091-5) 64
HDV replicative activity parallels the production of the three HBsAg forms (Large, Middle and Small HBsAg) and its pathogenetic impact is exacerbated by concomitant HBV replication 63
Superiority of the new sex-adjusted models to remove the female disadvantage restoring equity in liver transplant allocation 63
Prevalence of hepatitis D virus infection in Central Italy has remained stable across the last 2 decades with dominance of subgenotypes 1 and characterized by elevated viral replication 62
HDV epidemic in Central Italy is stable over the last two decades and is characterized by the circulation of multiple HDV subgenotypes 1 inducing different inflammatory stimuli 62
The role of antiplatelet therapies on incidence and mortality of hepatocellular carcinoma 61
Fairness and pitfalls of the Italian waiting list for elective liver transplantation: The ECALITA registry study 59
Higher levels of three HBsAg forms (Large, Middle and Small HBsAg) are associated with HDV replication and with the degree of disease and liver damage. 58
Stable temporal trend of HDV seroprevalence in central Italy across the last two decades with the circulation of HDV sub-genotypes 1 inducing different inflammatory stimuli 57
Sarco-Model: A score to predict the dropout risk in the perspective of organ allocation in patients awaiting liver transplantation 56
Role of Cone-Beam CT in the Intraprocedural Evaluation of Chemoembolization of Hepatocellular Carcinoma 56
The intrahepatic activity of Hepatitis Delta virus is sustained by an abundant production of HBs transcripts, mainly derived from integrated HBV-DNA, and is not strictly related to the extent of HBV reservoir 55
The Italian data on SARS-CoV-2 infection in transplanted patients support an organ specific immune response in liver recipients 53
The acquisition of positively charged amino acids in HBsAg C- terminus impairs HBsAg secretion, affects its structural stability and is associated with HBV-induced liver cancer 53
Waiting list mortality and 5-year transplant survival benefit of patients with MASLD: An Italian liver transplant registry study 52
New strategies on management of hepatitis B virus after liver transplantation: complete and sustained weaning of HBV prophylaxis in a selected cohort of patients transplanted due to HBV-related cirrhosis 51
THE ENRICHMENT OF POSITIVELY CHARGED AMINO ACIDS IN HBsAg C-TERMINUS IMPAIRS HBsAg SECRETION, AFFECTS ITS STRUCTURAL STABILITY AND IS CORRELATED WITH HBV-INDUCED LIVER CANCER. 50
PATHWAYS UNDERLYING HDV PERSISTENCE ACT INDEPENDENTLY FROM THE EXTENT OF HBV RESEVOIR AND ARE SUSTAINED BY AN ABUNDANT PRODUCTION OF HBSAG DERIVED FROM INTEGRATED HBV-DNA P 214 49
HDV INFECTION IS STABLE IN CENTRAL ITALY ACROSS THE LAST TWO DECADES AND IS CHARACTERIZED BY THE CIRCULATION OF MULTIPLE HDV SUB-GENOTYPES 1 WITH A DIFFERENT PRO-INFLAMMATORY POTENTIAL 48
Sequence of events leading to primary biliary cholangitis 48
Chronic HDV coinfection (CHD) is characterized by a different HBsAg isoforms composition respect to HBV mono-infection with higher middle- and large-HBs levels paralleling the replicative and cytolytic activity of HDV. 47
Repeated TACE in HCC after Fontan surgery and situs viscerum inversus: A case report 47
Benign disease and unexpected histologocal findings after pancreaticoduodenectomy: The role of endoscopic ultrasound fine needle aspiration 46
Development of Autoimmune Hepatitis after COVID-19 Infection in Vaccinated Women 44
A peculiar HBsAg isoforms composition characterizes chronic HDV coinfection respect to HBV mono-infection, with higher middle-/large-HBs levels paralleling HDV activity. 43
Reduction in bile leaks following adult split liver transplant using a fibrin-collagen sponge: A pilot study 43
null 42
Use of intravascular ultrasound to improve diagnosis and treatment of transjugular intrahepatic portosystemic shunt dysfunction in patients in the long-term follow-up 41
The Many Faces of Metabolic Dysfunction-Associated Fatty Liver Disease Treatment: From the Mediterranean Diet to Fecal Microbiota Transplantation 39
Chronic HDV coinfection (CHD) is characterized by a more elevated production of Middle and Large HBsAg than HBV mono-infection, that parallels HDV replicative and cytolytic activity. 38
The Effects of Sustained Immunosuppression Withdrawal After Liver Transplantation on Metabolic Syndrome 38
Saline Contrast Echocardiography in Patients With Hepatopulmonary Syndrome Awaiting Liver Transplantation 34
Chronic HDV coinfection is characterized by a peculiar HBsAg isoforms composition respect to HBV mono-infection, with higher middle-/large-HBs levels paralleling HDV activity. 34
HBsAg production from integrated HBV-DNA sustains HDV persistence in the setting of a limited or even absent HBV reservoir 34
Moving forward in the treatment of cholangiocarcinoma 32
Chronic HDV infection is sustained by an intense HBsAg production fromintegrated HBVDNA in the setting of a limited or even absent HBV reservoir. 32
HDV persistence is sustained by HBsAg mainly derived from integrated HBV-DNA and is independent from the extent of HBV reservoir 32
Pathways sustaining HDV activity act independently from the size of HBV resevoir and are fueled by an abundant expression of HBsAg from integrated HBV-DNA 32
Sarco-Model: a score to predict the dropout risk in the perspective of organ allocation in patients awaiting liver transplantation 31
null 22
Successful ongoing retreatment with glecaprevir/pibrentasvir + sofosbuvir + ribavirin in a patient with HCV genotype 3 who failed glecaprevir/pibrentasvir with both NS3 and NS5A resistance 17
Totale 11.626
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.249
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.249
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021902 0 0 0 0 0 273 252 212 27 81 30 27
2021/2022606 28 62 18 27 9 72 46 24 71 60 38 151
2022/2023805 75 79 46 88 80 156 72 72 73 11 32 21
2023/2024478 60 16 43 13 62 135 9 14 14 54 3 55
2024/20252.589 56 347 205 105 28 183 169 60 172 181 622 461
2025/20262.096 426 147 416 421 364 322 0 0 0 0 0 0
Totale 11.626